ENVB.NASDAQEnveric Biosciences, INC

SCHEDULE 13G/A: AdvisorShares Trust Discloses Passive 3.65% Stake in Enveric Biosciences

Sentiment:

Beneficial Ownership Disclosure

📋All filings for Enveric Biosciences, INC
🔒Login to Follow

AdvisorShares Trust has filed an amended Schedule 13G, reporting a passive beneficial ownership of 3.65% in Enveric Biosciences, Inc. as of March 31, 2025.

Summary

  • AdvisorShares Trust filed an Amendment No. 1 to Schedule 13G concerning its ownership in Enveric Biosciences, Inc.
  • The filing indicates that AdvisorShares Trust beneficially owns 90,324 shares of Enveric Biosciences, Inc. Common Stock.
  • This ownership represents 3.65% of the total class of securities.
  • AdvisorShares Trust holds sole voting power and sole dispositive power over all 90,324 shares.
  • The filing certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: Neutral, as this is a routine disclosure of passive ownership and does not contain performance or strategic information.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of passive institutional ownership and does not provide broader industry context or trends.

Stakeholder Impact

  • Shareholders: Provides transparency regarding institutional ownership, confirming a passive stake by AdvisorShares Trust.

Key Dates

DateDescription
03/31/2025Date of event which requires filing of this statement
04/02/2025Date of signing the Schedule 13G

Keywords

Enveric Biosciences, AdvisorShares Trust, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Passive Investment, Institutional Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.